First-in-Human Single and Multiple Dose of GLPG2222
Clinical trial NCT02662452 · COMPLETED
Trial details
- NCT number
- NCT02662452
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.